Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
Sci Transl Med
; 14(636): eabg8402, 2022 03 16.
Article
in En
| MEDLINE
| ID: mdl-35294258
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Indoleamine-Pyrrole 2,3,-Dioxygenase
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Sci Transl Med
Journal subject:
CIENCIA
/
MEDICINA
Year:
2022
Type:
Article
Affiliation country:
United States